Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Synsorb Biotech searches for treatments for bacterial toxin-induced diseases

Sep. 13, 1999

New naturally occurring hepatoprotective/immunostimulating compound from Il Yang in phase II

Sep. 10, 1999

Licensing opportunity from NIH: antisense oligonucleotides for treating Crohn's disease

Sep. 9, 1999

Isis reacquires full rights to ISIS-2302 and negotiates with commercialization partners

Sep. 7, 1999

Nabi hepatitis C drug shows promise in chimpanzee study

Sep. 6, 1999

Shenyang Pharmaceutical University synthesizes new antiulcer benzimidazoles

Sep. 3, 1999

New ulcer drug approved for the first time in Japan

Sep. 1, 1999

Lotronex NDA gets priority review from FDA

Sep. 1, 1999

Eisai's proton pump inhibitor approved in E.U. for GERD maintenance

Sep. 1, 1999

Glaxo Wellcome proposes to discontinue Wellferon

Aug. 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...